Table 1.
Italian HPV vaccine schedules.
HPV Vaccine Formulation | Age (Females) | Doses | Schedule |
---|---|---|---|
Bivalent vaccine | 9–14 * | 2 doses | dose 1: 0 mo |
dose 2: 5–7 mo | |||
over 14 | 3 doses | dose 1: 0 mo | |
dose 2 +: 1 mo | |||
dose 3 +:6 mo | |||
Quadrivalent vaccine | 9–13 * | 2 doses | dose 1: 0 mo |
dose 2 ^: 6 mo | |||
9–13 * | 3 doses | dose 1: 0 mo | |
dose 2 §: 2 mo | |||
dose 3 §: 6 mo | |||
14 and over | 3 doses | dose 1: 0 mo | |
dose 2 §: 2 mo | |||
dose 3 §: 6 mo | |||
Nonavalent vaccine | 9–14 * | 2 doses | dose 1: 0 mo |
dose 2 ^: 5–13 mo | |||
9–14 * | 3 doses | dose 1: 0 mo | |
dose 2 §: 2 mo | |||
dose 3 §: 6 mo | |||
over 14 | 3 doses | dose 1: 0 mo | |
dose 2 §: 2 mo | |||
dose 3 §: 6 mo |
mo: month; * included; + the second dose should be administered 1 to 2.5 months after the first dose, the third dose 5 to 12 months after the first dose; ^ if the second dose is administered five months or earlier after the first dose, a third dose should always be administered; § the second dose at least one month after the first dose and the third dose at least three months after the second dose; the three doses must be administered within one year.